or Try an Advanced Search...

    Technical Analysis for TNXP - Tonix Pharmaceuticals Holding Corp.

    Grade Last Price % Change Price Change
    D 0.19 16.78% 0.03
    TNXP closed up 16.78 percent on Wednesday, November 20, 2024, on 18.86 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical TNXP trend table...
    Date Alert Name Type % Chg
    Gilligan's Island Sell Setup Bearish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Volume Surge Other 0.00%
    Wide Range Bar Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Bullish Engulfing Bullish 16.78%
    Crossed Above 20 DMA Bullish 16.78%
    Older End-of-Day Signals for TNXP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 19 hours ago
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    3x Volume Pace about 22 hours ago
    10x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    TNXP Chart by TradingView
    Basic chart:

    Profile

    Tonix Pharmaceuticals Holding Corp., a development stage specialty pharmaceutical company, focuses on the development of pharmaceutical products for the disorders of central nervous system. The company's lead product candidate includes TNX-102 SL, a dose and formulation of cyclobenzaprine for the treatment of fibromyalgia and post-traumatic stress disorder. It also has a pipeline of various other product candidates, including TNX-201, which is a treatment for certain types of headaches; and TNX-301. The company was founded in 2007 and is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Health Sciences Drugs Pharmaceutical Products Disorders Post Traumatic Stress Disorder Headache Stage Specialty Pharmaceutical Fibromyalgia Seth Lederman

    Is TNXP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
    Nov 18 Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
    Nov 14 Tonix Pharmaceuticals Targets Rapid Migraine Relief With Non-Oral Treatments
    Nov 13 Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
    Nov 13 Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals
    Nov 12 Tonix Pharmaceuticals GAAP EPS of -$0.23 beats by $3.65, revenue of $2.82M misses by $0.33M
    Nov 5 Tonix Pharma Partners for Vaccine Clinical Trial
    Nov 4 Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
    Nov 1 Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
    Oct 29 Tonix Pharmaceuticals to Present at BIO-Europe® 2024
    See more TNXP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.1376
    52 Week Low 0.118
    Average Volume 35,100,557
    200-Day Moving Average 3.59
    50-Day Moving Average 0.15
    20-Day Moving Average 0.15
    10-Day Moving Average 0.15
    Average True Range 0.02
    RSI (14) 65.64
    ADX 19.07
    +DI 53.46
    -DI 11.90
    Chandelier Exit (Long, 3 ATRs) 0.20
    Chandelier Exit (Short, 3 ATRs) 0.20
    Upper Bollinger Bands 0.18
    Lower Bollinger Band 0.12
    Percent B (%b) 1.15
    BandWidth 41.17
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.005
    Fundamentals Value
    Market Cap 11.14 Million
    Num Shares 58.6 Million
    EPS -9.26
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 4.85
    Price-to-Book 0.16
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.33
    Resistance 3 (R3) 0.34 0.31 0.31
    Resistance 2 (R2) 0.31 0.27 0.30 0.30
    Resistance 1 (R1) 0.25 0.25 0.23 0.24 0.29
    Pivot Point 0.22 0.22 0.21 0.21 0.22
    Support 1 (S1) 0.16 0.18 0.14 0.14 0.09
    Support 2 (S2) 0.12 0.16 0.12 0.08
    Support 3 (S3) 0.06 0.12 0.07
    Support 4 (S4) 0.05